Nanotechnology is a new concept that will soon become the pinnacle of science and technology. It penetrates using nanometer-sized molecules and has demonstrated its worth in space, medicine, and other fields of science. Because the eye is a small organ that can be easily accessed due to its exposed location, it is an ideal target for nanotechnology. It appears that the "discovery of nanomedicines has reawakened huge aspirations for ophthalmic pharmacotherapy, in which nanostructured drugs are predicted to pass through the eye's limiting barriers." Safe manufacturing procedures and unforeseen biological repercussions of nanomaterial use remain barriers to nanotechnology adoption. These challenges are not insurmountable, and this developing sector is likely to yield innovative treatments for ocular disorders.
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : White-dot syndrome like presentation secondary to ibrutinib therapy : A case report
Shailja Chalishazar, Cardiff and Vale University Health Board, United Kingdom
Title : The usual suspects: Bilateral astrocytic hamartomas in tuberous sclerosis
Nishi Meghna Satish, VMMC & Safdarjung Hospital, India
Title : Knowledge, attitude and practice of diabetic retinopathy amongst diabetic patients in a tertiary care hospital in jammu north india
Pallavi Sharma, Govt. Medical college Jammu, University of Jammu, India
Title : To compare Anesthetic efficacy and pupillary dilation dynamics of combined vs. standard topical regime in phacoemulsification surgery
Kanavdeep Kapoor, ASCOMS, Jammu, India
Title : A study on ocular morbidities in children aged between 7 to 18 years attending ophthalmology OPD in Al Ameen Medical College and Hospital Bijapur
Ayesha Batool, Al Ameen Medical College and Hospital Bijapur, India